Cornelis P. Vlaar

1.2k total citations
44 papers, 812 citations indexed

About

Cornelis P. Vlaar is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Cornelis P. Vlaar has authored 44 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Organic Chemistry. Recurrent topics in Cornelis P. Vlaar's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Cancer-related Molecular Pathways (8 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (5 papers). Cornelis P. Vlaar is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Cancer-related Molecular Pathways (8 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (5 papers). Cornelis P. Vlaar collaborates with scholars based in Puerto Rico, United States and Belgium. Cornelis P. Vlaar's co-authors include Eliud Hernandez O'Farril, Suranganie Dharmawardhane, Linette Castillo‐Pichardo, Tessa Humphries‐Bickley, Luis A. Cubano, Joachim Rudolph, K. Barry Sharpless, Peter Sennhenn, Alina De La Mota‐Peynado and Anjaneyulu Kowluru and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Cornelis P. Vlaar

38 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelis P. Vlaar Puerto Rico 14 476 229 188 124 62 44 812
Eliud Hernandez O'Farril Puerto Rico 15 412 0.9× 246 1.1× 158 0.8× 124 1.0× 62 1.0× 31 755
Madhu Mahankali United States 14 364 0.8× 198 0.9× 111 0.6× 70 0.6× 55 0.9× 17 574
K. M. Błażewska Poland 19 433 0.9× 288 1.3× 101 0.5× 315 2.5× 37 0.6× 43 962
Christine Lambert‐van der Brempt United Kingdom 11 520 1.1× 331 1.4× 53 0.3× 243 2.0× 72 1.2× 20 925
Thomas Bohnacker Switzerland 16 624 1.3× 177 0.8× 71 0.4× 103 0.8× 39 0.6× 23 889
Christina Esdar Germany 15 460 1.0× 86 0.4× 63 0.3× 182 1.5× 45 0.7× 38 698
Ulrich Klar Germany 17 355 0.7× 214 0.9× 164 0.9× 482 3.9× 65 1.0× 41 951
F. Gessier Switzerland 16 559 1.2× 329 1.4× 55 0.3× 213 1.7× 31 0.5× 25 897
Michael Ebner Austria 12 596 1.3× 160 0.7× 209 1.1× 26 0.2× 31 0.5× 19 916
Sylvia Musto United States 18 466 1.0× 216 0.9× 160 0.9× 328 2.6× 36 0.6× 32 943

Countries citing papers authored by Cornelis P. Vlaar

Since Specialization
Citations

This map shows the geographic impact of Cornelis P. Vlaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis P. Vlaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis P. Vlaar more than expected).

Fields of papers citing papers by Cornelis P. Vlaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelis P. Vlaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis P. Vlaar. The network helps show where Cornelis P. Vlaar may publish in the future.

Co-authorship network of co-authors of Cornelis P. Vlaar

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelis P. Vlaar. A scholar is included among the top collaborators of Cornelis P. Vlaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelis P. Vlaar. Cornelis P. Vlaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, Martin J., Suli Zhang, Daniel Zhang, et al.. (2025). VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer. Molecular Cancer Research. 23(8). 684–698. 1 indexed citations
2.
Vlaar, Cornelis P., Jean‐Christophe M. Monbaliu, Rodolfo J. Romañach, et al.. (2024). A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities. International Journal of Pharmaceutics. 670. 125070–125070. 1 indexed citations
3.
Vivas‐Mejía, Pablo E., et al.. (2024). Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer. Translational Oncology. 44. 101928–101928. 1 indexed citations
4.
López-Mejías, Vilmalí, et al.. (2024). Continuous flow synthesis and crystallization of modafinil: a novel approach for integrated manufacturing. Reaction Chemistry & Engineering. 9(10). 2728–2739.
5.
6.
O'Farril, Eliud Hernandez, et al.. (2023). The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer. Molecular Medicine. 29(1). 75–75.
7.
Maldonado, María del Mar, Mariana Cooke, Marcelo G. Kazanietz, et al.. (2022). Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42. Cancer Research Communications. 2(12). 1711–1726. 10 indexed citations
8.
Emmanuel, Noémie, Vilmalí López-Mejías, Jorgé Duconge, et al.. (2022). Out-smarting smart drug modafinil through flow chemistry. Green Chemistry. 24(5). 2094–2103. 11 indexed citations
9.
Bayro, Marvin J., et al.. (2020). Abstract 4018: Interaction site elucidation of the Rac1/Cdc42 inhibitor, MBQ-167. Cancer Research. 80(16_Supplement). 4018–4018. 1 indexed citations
10.
Maldonado, María del Mar, Jorgé Duconge, Jean F. Ruiz-Calderón, et al.. (2019). Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry. ACS Omega. 4(19). 17981–17989. 12 indexed citations
11.
Humphries‐Bickley, Tessa, Linette Castillo‐Pichardo, Eliud Hernandez O'Farril, et al.. (2017). Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer. Molecular Cancer Therapeutics. 16(5). 805–818. 72 indexed citations
12.
Vlaar, Cornelis P., et al.. (2017). Abstract 181: Discovery of novel targeted therapeutics for metastatic breast cancer. Cancer Research. 77(13_Supplement). 181–181.
13.
Veluthakal, Rajakrishnan, Ragadeepthi Tunduguru, Daleep K. Arora, et al.. (2015). VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells. PMC. 1 indexed citations
14.
Humphries‐Bickley, Tessa, Linette Castillo‐Pichardo, Jorgé Duconge, et al.. (2015). Pharmacokinetics of Rac inhibitor EHop-016 in mice by ultra-performance liquid chromatography tandem mass spectrometry. Journal of Chromatography B. 981-982. 19–26. 27 indexed citations
15.
Veluthakal, Rajakrishnan, Ragadeepthi Tunduguru, Daleep K. Arora, et al.. (2015). VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells. Diabetologia. 58(11). 2573–2581. 34 indexed citations
16.
Castillo‐Pichardo, Linette, Tessa Humphries‐Bickley, Columba de la Parra, et al.. (2014). The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model. Translational Oncology. 7(5). 546–555. 64 indexed citations
17.
Martin, Holly, Raghuveer Singh Mali, Peilin Ma, et al.. (2013). Pak and Rac GTPases promote oncogenic KIT–induced neoplasms. Journal of Clinical Investigation. 123(10). 4449–4463. 37 indexed citations
18.
Dharmawardhane, Suranganie, Eliud Hernandez O'Farril, & Cornelis P. Vlaar. (2013). Development of EHop-016. ˜The œEnzymes. 33 Pt A. 117–146. 29 indexed citations
19.
O'Farril, Eliud Hernandez, et al.. (2007). Synthesis of 1,4-dihydro-benzo[d][1,3]oxazin-2-ones from phthalides via an aminolysis-Hofmann rearrangement protocol. Tetrahedron Letters. 48(51). 8972–8975. 39 indexed citations
20.
Rudolph, Joachim, Peter Sennhenn, Cornelis P. Vlaar, & K. Barry Sharpless. (1996). Osmiumkatalysierte asymmetrische Aminohydroxylierung: kleinere Substituenten am Stickstoffatom erleichtern die Reaktion. Angewandte Chemie. 108(23-24). 2991–2995. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliud Hernandez O'Farril Breakdown of academic impact, for papers by Madhu Mahankali Breakdown of academic impact, for papers by K. M. Błażewska Breakdown of academic impact, for papers by Christine Lambert‐van der Brempt Breakdown of academic impact, for papers by Thomas Bohnacker Breakdown of academic impact, for papers by Christina Esdar Breakdown of academic impact, for papers by Ulrich Klar Breakdown of academic impact, for papers by F. Gessier Breakdown of academic impact, for papers by Michael Ebner Breakdown of academic impact, for papers by Sylvia Musto
Rankless by CCL
2026